Investor Relations

Press Releases

All Releases
  REVA Arranges Convertible Note Financing
Apr 24, 2017
PDF 148.6 KB Add to Briefcase
  Prospectus for Offering of Convertible Notes and Options
Apr 24, 2017
PDF 864.5 KB Add to Briefcase
  Convertible Note Financing Arranged
Apr 24, 2017
PDF 198.2 KB Add to Briefcase
  Announcement of buy-back - Appendix 3C
Apr 24, 2017
PDF 149.6 KB Add to Briefcase
  REVA to Present at EuroPCR 2017
Apr 12, 2017
PDF 151.2 KB Add to Briefcase
  REVA to Present at EuroPCR 2017
Apr 11, 2017
PDF 152.6 KB Add to Briefcase
  REVA Receives CE Mark for Fantom
Apr 4, 2017
PDF 149.5 KB Add to Briefcase
  REVA Receives CE Mark for Fantom
Apr 3, 2017
PDF 151.1 KB Add to Briefcase
  Appendix 4G
Mar 30, 2017
PDF 149.1 KB Add to Briefcase
  Appendix 3B
Mar 27, 2017
PDF 297.5 KB Add to Briefcase
  FANTOM II Trial to be Expanded to More Complex Cases
Mar 24, 2017
PDF 151.4 KB Add to Briefcase
  REVA to Expand FANTOM II Trial to More Complex Cases
Mar 23, 2017
PDF 153.3 KB Add to Briefcase
  Appendix 4C - quarterly (revised)
Mar 17, 2017
PDF 254.7 KB Add to Briefcase
  Notice of Briefing Call
Mar 9, 2017
PDF 134.6 KB Add to Briefcase
  Notice of Briefing Call
Mar 8, 2017
PDF 137.1 KB Add to Briefcase
  Form S-8 Filed with SEC
Mar 1, 2017
PDF 211.2 KB Add to Briefcase
  Preliminary Final Report and Annual Report on Form 10-K
Feb 28, 2017
PDF 806.6 KB Add to Briefcase
  Change in substantial holding
Feb 20, 2017
PDF 178.7 KB Add to Briefcase
  Appendix 4C - quarterly
Jan 31, 2017
PDF 272.8 KB Add to Briefcase
  REVA to Present at J.P. Morgan Healthcare Conference
Jan 10, 2017
PDF 134.4 KB Add to Briefcase
Showing 1-20 of 441 Page: 1 2 3 4 5 ... 23  Next 20
Add to Briefcase = add release to Briefcase